LifeSci Partners Genetic Medicines Symposium
About The Event
|LifeSci Partners is hosting our 2nd Annual virtual Genetic Medicines Symposium on June 28th and 29th and will consist of virtual discussions with key opinion leaders (KOLs), as well as presentations/fireside chats with 30+ public and private companies focused on the development of genetic medicines.
The potential of genetic medicines has never been greater, spanning gene therapies capable of curing fatal orphan diseases to highly adaptable vaccines with pandemic-ending abilities. Driving this era of innovation is an ever-expanding genetic medicines toolbox, highlighted by technologies like adeno-associated viruses (AAV), lipid nanoparticles (LNP), anti-sense oligonucleotides (ASO), RNA interference (RNAi), messenger RNA (mRNA), CRISPR, base editors, RNA-editors, and cell therapies, among others. As this diverse array of technology continues to be coupled with a greater understanding of underlying genetics and pathogenesis of disease, creative solutions to previously incomprehensible biological problems feel attainable. As such, LifeSci Partners is pleased to host a selection of some of the most dynamic companies pioneering genetic medicines, who will have the opportunity to present to our extensive global network of investors and potential strategic partners.